Applied Fundamental Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$2.83M |
| 2 |
PPLI
People Inc
PPLI
|
+$2.33M |
| 3 |
Match Group
MTCH
|
+$1.42M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$950K |
| 5 |
TTEC Holdings
TTEC
|
+$927K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco
IVZ
|
+$12.3M |
| 2 |
UFP Technologies
UFPT
|
+$3.78M |
| 3 |
Dycom Industries
DY
|
+$3.46M |
| 4 |
Nomad Foods
NOMD
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.48% |
| 2 | Industrials | 23.7% |
| 3 | Communication Services | 21.34% |
| 4 | Real Estate | 10.39% |
| 5 | Technology | 10.38% |
Similar funds
Applied Fundamental Research's Q2 2022 Portfolio in Review
As of Q2 2022, Applied Fundamental Research held 11 positions worth $179M, down 19% from $222M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Applied Fundamental Research withdrew a net $12.1M in Q2 2022, closing 1 position and reducing 3 holdings. Its most notable exit was Invesco, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Applied Fundamental Research added an estimated $2.83M to PetIQ, Inc. Class A Common Stock.
- Applied Fundamental Research added most to PetIQ, Inc. Class A Common Stock in Q2 2022, an estimated $2.83M increase.
- Applied Fundamental Research's biggest Q2 2022 reduction was UFP Technologies, cutting an estimated $3.78M.
- Applied Fundamental Research fully exited Invesco in Q2 2022, selling an estimated $12.3M.
- Applied Fundamental Research's ten largest holdings make up 100% of its $179M portfolio in Q2 2022.
- Applied Fundamental Research opened 0 new positions and closed 1 in Q2 2022.
- Applied Fundamental Research's portfolio value fell 19% quarter-over-quarter to $179M.
Based on Applied Fundamental Research's 13F filing for Q2 2022, filed 15 Aug 2022.